WASHINGTON: A new experimental treatment against Alzheimer's has proved to be promising and free of harmful side effects, researchers in the United States reported Wednesday. The research published in the journal Science Translational Medicine on the basis of a small 32-person sample gave rise to two broader clinical trials that are now underway with more than 3,000 subjects. The treatment uses a compound called verubecestat, developed by US pharmaceutical firm. It reduces levels of proteins called beta amyloids by…
WASHINGTON: A cancer drug may be helpful in improving memory and motor skills in patients with Parkinson's disease, according to preliminary research presented at a US medical conference this weekend.
WASHINGTON: A protein that appears to be key in the development of Alzheimer's disease has been identified by scientists who say the discovery could provide a new drug target for dementia.